Home › Funds › DWS › DWS Small Cap Core Fund
Fund family: DWS · Filed by DEUTSCHE DWS INVESTMENT TRUST (CIK 88064) · SEC series S000005709
Share classes and tickers: SSLCX (C000015700), SZCAX (C000015696), SZCCX (C000015699), SZCIX (C000172344), SZCRX (C000172343)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 797 with, 14 against, 0 abstentions (not counted as with management); 2 items carried no recommendation. Shareholder proposals: 6 FOR, 1 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as DWS’s manager page (256,084 ballot items across 82 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | DWS | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 93.5% | 773 | 91.4% | 200,577 |
| Backed environmental and social shareholder proposals at US companies | n/a | 1 | 31.1% | 2,251 |
Each ballot item this fund voted is set against the votes of the other DWS funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most DWS funds on all 326 items where a comparison was possible.
The same votes as “with management” above, by the sector of the company voted on. 93.2% of this fund’s 811 such votes could be given a sector; the other 55 (6.8%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 165 | 9 | 5.5% |
| Consumer Discretionary | 106 | 3 | 2.8% |
| Industrials | 97 | 2 | 2.1% |
| Energy | 85 | 0 | 0.0% |
| Technology | 79 | 0 | 0.0% |
| Finance | 61 | 0 | 0.0% |
| Real Estate | 57 | 0 | 0.0% |
| Utilities | 41 | 0 | 0.0% |
| Consumer Staples | 28 | 0 | 0.0% |
| Miscellaneous | 21 | 0 | 0.0% |
| Telecommunications | 16 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 551 | 9 |
| Say-on-Pay | 95 | 0 |
| Audit-related | 88 | 0 |
| Compensation | 35 | 0 |
| Corporate Governance | 28 | 4 |
| Extraordinary Transactions | 12 | 0 |
| Capital Structure | 7 | 0 |
| Diversity, Equity, and Inclusion | 1 | 1 |
| Other Social Issues | 1 | 0 |
| Shareholder Rights and Defenses | 1 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Ligand Pharmaceuticals Incorporated | June 5, 2026 | $75M | 11 | 0 |
| The Bancorp, Inc. | May 27, 2026 | $36M | 12 | 0 |
| Selective Insurance Group, Inc. | April 29, 2026 | $26M | 14 | 0 |
| IDT Corporation | December 11, 2025 | $26M | 6 | 0 |
| Stride, Inc. | December 4, 2025 | $25M | 12 | 0 |
| Nextracker Inc. | August 18, 2025 | $25M | 5 | 0 |
| RadNet, Inc. | June 2, 2026 | $19M | 9 | 0 |
| Match Group, Inc. | June 16, 2026 | $18M | 7 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| June 9, 2026 | Pacira Biosciences, Inc. | Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Oliver Benton Curtis III Shareholder proposal | Withhold | For |
| June 9, 2026 | Pacira Biosciences, Inc. | Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Eric de Armas Shareholder proposal | Withhold | For |
| April 28, 2026 | The Brink's Company | Act upon a shareholder proposal requesting a report on employee retention rates by demographic categories. Shareholder proposal | Against | For |
| July 11, 2025 | Brookdale Senior Living Inc. | Election of eight (8) nominees to serve as directors to the Board for a one-year term ending at the Company's next annual meeting of stockholders and until his or her successor has been duly elected and qualified. COMPANY NOMINEES OPPOSED BY ORTELIUS: Jordan R. Asher | For | Against |
| July 11, 2025 | Brookdale Senior Living Inc. | Election of eight (8) nominees to serve as directors to the Board for a one-year term ending at the Company's next annual meeting of stockholders and until his or her successor has been duly elected and qualified. COMPANY NOMINEES OPPOSED BY ORTELIUS: Claudia N. Drayton | For | Against |
| June 3, 2026 | Resideo Technologies, Inc. | Shareholder Proposal Regarding Shareholder Right to Act by Written Consent. Shareholder proposal | For | Against |
| May 14, 2026 | Calix, Inc. | To hold an advisory vote on a stockholder proposal relating to a simple majority vote. Shareholder proposal | For | Against |
| May 12, 2026 | Group 1 Automotive, Inc. | Shareholder Proposal: Give Shareholders an Ability to Call for a Special Shareholder Meeting. Shareholder proposal | For | Against |
| May 21, 2026 | Meritage Homes Corporation | Shareholder proposal to improve shareholder ability to call for a special shareholder meeting. Shareholder proposal | For | Against |
Meetings with a proxy contest or competing nominees (2 in 2025-2026), and how the fund voted the items on its ballot.
819 ballot items at 98 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, DWS Small Cap Core Fund (SSLCX) voted at 98 shareholder meetings of 93 companies, on 819 ballot items in all. Where management made a recommendation, the fund followed it on 98.3% of the items and voted against it 14 times. Its most frequent area of disagreement was director elections (9 of its votes against management). It voted on 14 shareholder proposals. It voted FOR the board's own proposals more often than DWS's funds as a whole (93.5% against 91.4%). It voted the same way as most DWS funds on every item where a comparison was possible. 2 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of DWS’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.